Enhancing Care Study in Patients After CABG
ConditionCoronary Artery Bypass
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese Academy of Medical Sciences, Fuwai Hospital
About this trial
Review the data of patients who underwent coronary artery bypass grafting (CABG) at the National Center for Cardiovascular Disease, Fuwai Hospital from January 2013 to June 2023 including medical history, head CT scan, and postoperative, including 30-day mortality, arrhythmia, cerebrovascular disease and intracerebral haemorrhage, etc. Case-control and retrospective cohort studies were conducted to explore the risk factors associated with early postoperative complications, examine their relationship with postoperative management, explore independent risk factors of compound complications, and build predictive models.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients accepted CABG enrolled from January 2013 to June 2023
Disqualifiers
patients discharged within 72 hours of admission
patients with an admission diagnosis of atrial fibrillation
patients underwent CABG as emergency surgery
patients underwent concurrent surgical treatments
Trial population
Patients who accepted coronary artery bypass graft and met the eligibility criteria are enrolled for this study.
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
30-day mortality
The proportion of patients who die within 30 days of being admitted to the hospital.
Time frame
30 daysSecondary outcomes
1
post-operative atrial fibrillation
The occurrence of atrial fibrillation after a patient has undergone surgery.
Time frame
Around the second postoperative day.2
MACE
A combination of several critical cardiovascular events may vary depending on the specific context of the study or clinical evaluation.
Time frame
Around the second postoperative day.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov